Correlates and analysis of motor function in humans and animal models of parkinson's disease

Neuromethods

Volumn 50, Issue , 2011, Pages 55-90

  Schang, Alexandra Y ^a,d   Fisher, Beth E ^a   Sashkin, Natalie R ^b   Moore, Cindy ^b   Dirling, Lisa B ^b   Petzinger, Giselle M ^c   Jakowec, Michael W ^c   Meshul, Charles K ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

electron microscopy; motor behavior; MPTP; Parkinson's disease

Indexed keywords

DOPAMINE; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2;

BODY EQUILIBRIUM; BODY MOVEMENT; CELL LOSS; DISEASE MODEL; ELECTROMYOGRAPHY; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; LABORATORY TEST; LOCOMOTION; MEDICAL RESEARCH; MOTOR CONTROL; MOTOR PERFORMANCE; MOUSE; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; REVIEW; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TASK PERFORMANCE; UNIFIED PARKINSON DISEASE RATING SCALE;

ANIMALIA; RATTUS; RODENTIA;

EID: 77957929071     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-60761-883-6_3     Document Type: Review

References (116)

1. Visser M, Marinus J, Bloem BR, Kisjes H, van den Berg BM, van Hilten JJ (2003) Clinical tests for the evaluation of postural instability in patients with Parkinson's disease. Arch Phys Med Rehabil 84: 1669-1674
2. Bloem BR, Beckley DJ, van Hilten BJ, Roos RAC (1998) Clinimetrics of postural instability in Parkinson's disease. J Neurol 245:669-673
3. Xu D, Carlton LG, Rosengren KS (2004) Anticipatory postural adjustments for altering direction during walking. J Mot Behav 36:316-326
4. Stack E, Jupp K, Ashburn A (2004) Devel-oping methods to evaluate how people with Parkinson's disease turn 180 degrees: an activity frequently associated with falls. Dis-abil Rehabil 26:478-484
5. Stack EL, Ashburn AM, Jupp KE (2006) Strategies used by people with Parkinson's disease who report difficulty turning. Parkin-sonism Relat Disord 12:87-92
6. Crenna P, Carpinella I, Rabufetti M, Cal-abrese E, Mazzoleni P, Nemni R, Fer-rarin M (2007) The association between impaired turning and normal straight walk-ing in Parkinson's disease. Gait Posture 26: 172-178
7. Willems A, Nieuwboer A, Chavret F, Desloo-vere K, Dom R, Rochester L, Kwakkel G, van Ween E, Jones D (2007) Turning in Parkinson's disease patients and controls: the effect of auditory cues. Mov Disord 22: 1871-1878
8. Movement Disorders Task Force (2003) The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommenda-tions. Mov Disord 18:738-750
9. Stebbins GT, Goetz CG (1998) Factor struc-ture of the Unified Parkinson's Disease Rat-ing Scale: motor examination section. Mov Disord 13:633-636
10. van Hilten JJ, van der Zwan AD, Zwinder-man AH, Roos RAC (1994) Rating impair-ment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale. Mov Disord 9:84-88
11. Richards M, Marder K, Cote L, Richard M (1994) Interrater reliability of the Uni-fied Parkinson's Disease Rating Scale motor examination. Mov Disord 9:89-91
12. Siderworf A, McDermott M, Kieburtz K, Blindauer K (2002) Test-retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: results from a multicenter clinical trial. Mov Disord 17:758-763
13. Song J, Fisher BE, Petzinger G, Wu A, Gor-don J, Salem GJ (2009) The relationship between the Unified Parkinson's Disease Rating Scale and lower extremity functional performance in persons with early-stage Parkinson's disease. Neurorehabil Neural Repair 23:657-661
14. Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement disorder society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129-2170
15. Podsiadlo D, Richardson S(1991) The timed "up & go": a test ofbasic functional mobil-ity for frail elderly persons. J Am Geriatr Soc 38:142-148
16. Rockwood K, Awalt E, Carver D, MacKight C (2000) Feasibility and measurement prop-erties of the functional reach and the timed up and go tests in the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci 55A:M70-M73
17. Steffen TM, Hacker TA, Mollinger L (2002) Age-and gender-related test performance in community-dwelling elderly people: six-minute walk test, Berg Balance Scale, timed up & go test, and gait speeds. Phys Ther 82:128-137
18. Thompson M, Medley A (1995) Perfor-mance of community dwelling elderly on the timed up and go test. Phys Occ Ther Ger 13:17-30
19. Shumway-Cook A, Brauer S, Woolacott M (2000) Predicting the probability for falls in community-dwelling older adults using the timed up & go test. Phys Ther 80:896-903
20. Morris S, Morris ME, Iansek R (2001) Reli-ability of measurements obtained with the timed "up & go" test in people with Parkin-son disease. Phys Ther 81:810-818
21. Lim LIIK, van Wegen EEH, de Goede CJT, Jones D, Rochester L, Hetherington V, Nieuboer A, Willems AM, Kwakkel G (2005) Measuring gait and gait-related activ-ities in Parkinson's patients own home envi-ronment: a reliability, responsiveness and fea-sibility study. Parkinsonism Relat Disord 11: 19-24
22. Campbell CM, Rowse JL, Ciol MA, Shumway-Cook A (2003) The effect ofcog-nitive demand on timed up and go per-formance in older adults with and without Parkinson disease. Neurol Rep 27:2-6
23. Blum L, Korner-Bitensky N (2008) Use-fulness of the Berg Balance Scale in stroke rehabilitation: a systematic review. Phys Ther 88:559-566
24. Landers MR, Backlund A, Davenport J, For-tune J, Schuerman S, Alktenburger P (2008) Postural instability in idiopathic Parkinson's disease: discriminating fallers from nonfall-ers based on standardized clinical measures. J Neurol Phys Ther 30:60-67
25. Muir SW, Berg K, Chesworth B, Speech-ley M (2008) Predicting multiple falls in community-dwelling elderly people: a prospective study. Phys Ther 88:449-459
26. Wee JY, Wong H, Palepu A (2003) Valida-tion of the Berg Balance Scale as a predictor oflength of stay and discharge destination in stroke rehabilitation. Arch Phys Med Rehabil 84:731-735
27. Bacher M, Scholz E, Diener HC (1989) 24 hour continuous tremor quantification based on EMG recording. Electroencephalogr Clin Neurophysiol 72:176-183
28. Qutubuddin AA, Pegg PO, Cifu DX, Brown R, McNamee S, Carne W (2005) Vali-dating the Berg Balance Scale for patients with Parkinson's disease: a key to rehabilita-tion evaluation. Arch Phys Med Rehabil 86: 789-792 (Pubitemid 40487848)
29. Steffen T, Seney M (2008) Test-retest relia-bility and minimal detectable change on bal-ance and ambulation tests, the 36-item short-form health survey, and the Unified Parkin-son Disease Rating Scale in people with parkinsonism. Phys Ther 88:733-746
30. Dibble LE, Lange M (2006) Predicting falls in individuals with Parkinson disease: a reconsideration of clinical balance measures. J Neurol Phys Ther 30:60-67
31. Breit S, Spieker S, Schulz JB, Gasser T (2008) Long-term EMG recordings differ-entiate between parkinsonian and essential tremor. JNeurol255:103-111
32. Scholz E, Bacher M, Diener HC, Dichgans J (1988) Twenty-four-hour tremor recordings in the evaluation of the treatment of Parkin-son's disease. J Neurol235:475-484
33. Sturman MM, Vaillancourt DE, Metman LV, Bakay RAE, Corcos DM (2004) Effects of subthalamic nucleus stimulation and medica-tion on resting and postural tremor in Parkin-son's disease. Brain 127:2131-2143
34. Blahak C, Bazner H, Capelle H, Wohrle JC, Weigel R, Henneriei MG, Krauss JK (2009) Rapid response of parkinsonian tremor to STN-DBS changes: direct modulation of oscillatory basal ganglia activity? Mov Disord 24:1221-1225
35. Bronte-Stewart HM, Ding L, Alexander C, Zhou Y, Moor GP (2000) Quantitative digi-tography (QDG): a sensitive measure ofdig-ital motor control in idiopathic Parkinson's disease. Mov Disord 15:36-47
36. Brusse KJ, Zimdars S, Zalewski KR, Steffen TM (2005) Testing functional performance in people with Parkinson disease. Phys Ther 85:134-141
37. Kelly VE, Hyngstrom AS, Rundle MM, Bas-tian AJ (2001) Interaction of levodopa and cues on voluntary reaching in Parkinson's disease. Mov Disord 17:38-44
38. Koop MM, Andrezejewski A, Hill BC, Heit G, Bronte-Stewart HM (2006) Improvement in a quantitative measure of bradykinesia after microelectrode recording in patients with Parkinson's disease during deep brain stimulation surgery. Mov Disord 21:673-678
39. Latt MD, Menz HB, Fung VS, Lord SR (2009) Acceleration patterns of the head and pelvis during gait in older people with Parkin-son's disease: a comparison of fallers and nonfallers. J Gerontol A Biol Sci Med Sci 64A:700-706
40. Koop MM, Shjivitz N, Bronte-Stewart H (2008) Quantitative measures offine motor, limb, and postural bradykinesia in very early stage, untreated Parkinson's disease. Mov Disord 23:1262-1268
41. Louie SL, Koop MM, Frenklach A, Bronte-Stewart H (2009) Quantitative lateralized measures of bradykinesia at different stages of Parkinson's disease: the role of the less affected side. Mov Disord 24:1991-1997
42. Kavanagh JJ, Menz HB (2008) Accelerom-etry: a technique for quantifying movement patterns during walking. Gait Posture 28: 1-15
43. Lord S, Rochester L, Baker K, Nieuwboer A (2008) Concurrent validity ofaccelerometry to measure gait in Parkinsons disease. Gait Posture 27:357-359
44. Saremi K, Marehbian J, Yan X, Regnaux J, Elashoff R, Bussel B, Dobkin BH (2006) Reliability and validity of bilateral thigh and foot accelerometry measures of walking in healthy and hemiparetic subjects. Neuroreha-bil Neural Repair 20:297-305
45. Windolf M, Gotzen N, Morlock M (2008) Systematic accuracy and precision analysis of video motion capturing systems-exempli-fied on the Vicon-460 system. J Biomech 41:2776-2780
46. Huxham F, Baker R, Morris ME, Iansek R (2008) Head and trunk rotation during walk-ing turns in Parkinson's disease. Mov Disord 23:1391-1397
47. Chien S, Lin S, Liang C, Soong Y, Lin S, Hsin Y, Lee C, Chen S (2006) The efficacy of quantitative gait analysis by the GAITRite system in evaluation of parkinso-nian bradykinesia. Parkinsonims Relat Disord 12:438-442
48. Nelson AJ, Zwick D, Brody S, Doran C, Pulver L, Rooz G, Sadownick M, Nelson R, Rothman J (2002) The validity of the GAITRite and the functional ambulation performance scoring system in the analy-sis of Parkinson gait. Neuro Reabilitation 17:255-262
49. Ferrarin M (2006) Locomotor disorders in patient at early stages ofParkinson's disease: a quantitative analysis. Conf Proc IEEE Eng Med Biol Soc 1:1224-1227
50. Oates AR, Frank JS, Patla AE, Van Ooteghem K, Horak FB (2008) Control ofdynamic sta-bility during gait termination on a slippery surface in Parkinson's disease. Mov Disord 23:1977-1983
51. Hof AL, Gazendam MG, Sinke WE (2005) The condition for dynamic stability. J Biomech 38:1-8
52. Song J, Fisher B, Sigward S, Petzinger G, Salem GJ (2008) The effect of early stage Parkinson's disease on dynamic postural sta-bility during turning activities. Paper presented at Society for Neuroscience Conference, Washington, DC
53. Dimitrova D, Horak FB, Nutt JG (2004) Postural muscle responses to multidirectional translations in patients with Parkinson's dis-ease. J Neurophysiol91:489-501 (Pubitemid 38084389)
54. Dimitrova D, Nutt J, Horak FB (2004) Abnormal force patterns for multidirectional postural responses in patients with Parkin-son's disease. Exp Brain Res 156:183-195 (Pubitemid 38626476)
55. Horak FB, Dimitrova D, Nutt JG (2005) Direction-specific postural instability in sub-jects with Parkinson's disease. Exp Neurol 193:504-521
56. Starr MS (1995a) Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 19:264-293
57. Starr MS (1995b) Antiparkinsonian actions of glutamate antagonists-alone and with L-DOPA: a review ofevidence and suggestions for possible mechanisms. J Neural Transm [P-D Sect] 10:141-185
58. Fonnum F (1984) Glutamate: a neurotrans-mitter in mammalian brain. J Neurochem 42:1-11
59. McGeorge AJ, Faull RLM (1989) The orga-nization of the projection from the cerebral cortex to the striatum in the rat. Neurosci. 29:503-537
60. Lacey CJ, Boyes J, Gerlach O, Chen L, Mag-ill PJ, Bolam JP (2005) GABA-B receptors at glutamatergic synapses in the rat striatum. Neurosci 136:1083-1095
61. Raju DV, Shah DJ, Wright TM, Hall RA, Smith Y (2006) Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments. J Comp Neurol499:231-243
62. Smith Y, Raju DV, Pare JF, Sidibe M (2004) The thalamostriatal system: a highly specific network of the basal ganglia circuitry. Trends Neurosci 27:520-527
63. Bouyer JJ, Park DH, Joh TH, Pickel VM (1984) Chemical and structural analysis of the relation between cortical inputs and tyro-sine hydroxylase-containing terminals in rat neostriatum. Brain Res 302:267-275
64. Freund TF, Powell JF, Smith AD (1984) Tyrosine hydroxylase-immunoreactive bou-tons in synaptic contact with identified striatonigral neurons, with particular ref-erence to dendritic spines. Neurosci 13: 1189-1215
65. Gundersen V, Ottersen OP, Storm-Mathisen J (1996) Selective excitatory amino acid uptake in glutamatergic nerve terminals and in glia in the rat striatum: quantitative elec-tron microscopic immunocytochemistry of exogenous (D)-aspartate and endogenous glutamate and GABA. Eur J Neurosci 8: 758-765
66. Meshul CK, Stallbaumer RK, Taylor B, Janowsky A (1994) Haloperidol-induced synaptic changes in striatum are associated with glutamate synapses. Brain Res 648: 181-195
67. Bamford NA, Robinson S, Palmiter R, Joyce JA, Moore C, Meshul CK (2004) Presy-naptic modulation of corticostriatal termi-nals in dopamine-deficiency. J Neurosci 24: 9541-9552
68. Morari M, O'Connor WT, Ungerstedt U, Fuxe J (1994) Dopamine D1 and D2 recep-tor antagonism differentially modulates stim-ulation of striatal neurotransmitter levels by Λ?-methyl-D-aspartic acid. Eur J Pharm 256:23-30
69. Nithianantharajah J, Hannan AJ (2006) Enriched environments, experience-dependent plasticity and disorders of the ner-vous system. Nature Rev 7:687-709
70. Yamamoto BK, Davy S (1992) Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J Neurochem 58:1736-1742
71. Zhang H, Sulzer D (2003) Glutamate spillover in the striatum depresses dopamin-ergic transmission by activating group I metabotropic glutamate receptors. J Neurosci 19:10585-10592
72. Sesack SR, Aoki C, Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106
73. Wang H, Pickel VM (2002) Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 442:392-404
74. Calabresi P, De Murtas M, Mercuri NB, Bernardi G (1992) Chronic neurolep-tic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. Ann Neurol 31:366-373
75. Tillerson JL, Caudle WM, Reveron ME, Miller GW (2003) Exercise induces behav-ioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's dis-ease. Neurosci 119:899-911
76. Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T (2001) Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 21: 4427-4435
77. Poulton NP, Muir GD (2005) Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-Parkinsonian rats. Exp Neurol 193:181-197
78. Metz GA, Whishaw IQ (2002) Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of fore-limb or hindlimb motor performance. Neuroscience 111:325-336
79. O'Dell SJ, Gross NB, Fricks AN, Casiano BD, Nguyen TB, Marshall JF (2007) Running wheel exercise enhances recovery from nigrostriatal dopamine injury with-out inducing neuroprotection. Neuroscience 144:1141-1151
80. Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW (2004) Exercise-induced behavioral recov-ery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 77:378-390
81. Baker DA, Xi ZX, Shen H, Swanson CJ, Kali-vas PW (2002) The origin and neuronal func-tion of in vivo nonsynaptic glutamate. J Neurosci 22:9134-9141
82. Meshul CK, Kamel D, Moore C, Kay TS, Krentz L (2002) Nicotine alters stri-atal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA lesioned rats. Exp Neurol 175:257-274
83. Bland ST, Gonzales RA, Schallert T (1999) Movement-related glutamate levels in rat hippocampus, striatum, and sensorimotor cortex. Neurosci Lett 277:119-122
84. Wolf ME, Xue CJ, Li Y, Wavak D (2000) Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mech-anism involving glutamate transporters and reactive oxygen species. J Neurochem 75: 1634-1644
85. Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF (1999) Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience 88:1-16
86. Meshul CK, Allen C (2000) Haloperidol reverses the changes in striatal glutamater-gic immunolabeling following a 6-OHDA lesion. Synapse 36:129-142
87. Cenci MA, Bjorklund. A (1993) Tran-section of corticostriatal afferents reduces amphetamine-and apomorphine-induced striatal Fos expression and turning behaviour in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Neurosci 5:1062-1072
88. Holschneider DP, Yang J, Guo Y, Maarek JM (2007) Reorganization of functional brain maps after exercise training: importance of cerebellar-thalamic-cortical pathway Brain Res 1184:96-107
89. Meeusen R, Smolders I, Sarre S, De Meir-leir K, Keizer H, Serneels M, Ebinger G, Michotte Y (1997) Endurance training effects on neurotransmitter release in rat striatum: an in vivo microdialysis study. Acta Physiol Scand 159:335-341
90. Farmer J, Zhao X, van Praag H, Wodtke K, Gage FH, Christie BR (2004) Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 124:71-79
91. Raju DV, Ahern TH, Shah DJ, Wright TM, Standaert DG, Hall RA, Smith Y (2008) Dif-ferential synaptic plasticity of the corticostri-atal and thalamostriatal systems in an MPTP-treated monkey model ofparkinsonism. Eur J Neurosci 27:1647-1658
92. Fremeau RT Jr, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, Bel-loccho EE, Fortin D, Storm-Mathisen J, Edwards RH (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31:247-260
93. Dietrich MO, Mantese CE, Porciuncula LO, Ghisleni G, Vinade L, Souza DO, Portela LV (2005) Exercise affects glutamate receptors in postsynaptic densities from cortical mice brain. Brain Res 1065:20-25
94. Phend KD, Weinberg RJ, Rustioni A (1992) Techniques to optimize post-embedding sin-gle and double staining for amino acid neurotransmitters. J Histochem Cytochem 40:1011-1020
95. Kaneko T, Fujiyama F, Hioki H (2002) Immunohistochemical localization of can-didates for vesicular glutamate transporters in the rat brain. J Comp Neurol 444: 39-62
96. Meredith GE, Kang UJ (2006) Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Movement Dis 21:1595-1606
97. Laviola G, Hannan AJ, Macri S, Solinas M, Jaber M (2008) Effects ofenriched environ-ment on animal models ofneurodegenerative diseases and psychiatric disorders. Neurobiol Dis 31:159-168
98. Mora F, Segovia G, del Arco A (2007) Aging, plasticity, and environmental enrich-ment: structural changes and neurotransmit-ter dynamics in several areas of the brain. Br Res Rev 55:78-88
99. Mora F, Segovia G, del Arco A (2008) Glutamate-dopamine-GABA interactions in the aging basal ganglia. Br Res Rev 58: 340-353
100. Bezard E, Dovero S, Belin D, Duconger S, Jackson-Lewis V, Przedborski S, Piazza PV, Gross CE, Jaber M (2003) Enriched environ-ment confers resistance to 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. J Neurosci 23:10999-11007
101. Fleming SM, Salcedo J, Fernagut PO, Rock-enstein E, Maslia E, Levine MS, Chesse-let MF (2004) Early and progressive sen-sorimotor anomalies in mice overexpressing wild-type human α-synuclein. Neurobio Dis 24:9434-9440
102. Fredriksson A, Danysz W, Quack G, Archer T (2001) Co-administration of memantine with sub/suprathreshold doses of L-Dopa restores motor behavior of MPTP-treated mice. J Neural Transmission 108:1435-1463
103. Sundström E, Fredriksson A, Archer T (1990) Chronic neurochemical and behav-ioral changes in MPTP-lesioned C57Bl/6 mice: a model for Parkinson's disease. Brain Res 528:181-188
104. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and mor-phology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegen 4:257-269
105. Unal-Çevik I, Kilinç M, Gürsoy-Özdemir Y, Gurer G., Dalkara T (2004) Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cau-tionarynote. Brain Res 1015:169-174
106. Kamens HM, Crabbe JC (2007) The parallel rod floor test: a measure of ataxia in mice. Nat Protocols 2:277-281
107. Kozell LB, Meshul CK (2001) The effects of acute or repeated cocaine administra-tion on nerve terminal glutamate within the rat mesolimbic system. Neuroscience 106: 15-25
108. Bezard E, Dovero S, Bioulac B, Gross CE (1997) Kinetics ofnigral degeneration in a chronic model ofMPTP-treated mice. Neurosci Lett 234:47-50
109. Ricaurte GA, Irwin I, Forno LS, DeLan-ney LE, Langston E, Langston JW (1987) Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Br Res 403:43-51
110. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Sudhof TC (2004) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and α-synuclein. Proc Natl Acad Sci (USA) 102:3413-3418
111. Novikova L, Garris BL, Garris DR, Lau YS (2006) Early signs of neuronal apop-tosis in the substantia nigra pars com-pacta of the progressive neurodegener-ative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Cell Neurosci 140: 67-76
112. Petroske E, Meredith GE, Callen S, Tot-terdell S, Lau YS (2001) Mouse model of Parkinsonism: a comparison between suba-cute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106:589-601
113. Amende I, Kale A, McCue S, Glazier S, Mor-gan JP, Hampton TG (2005) Gait dynam-ics in mouse models of Parkinson's disease and Huntington's disease. J Neuroeng Reha-bil 2:20-33
114. Nutt JG, Hammerstad JP, Gancher ST (1992) Parkinson's disease: 100 maxims. Edward Arnold, London
115. Fahn S, Elton RL and UPDRS Develop-ment Committee (1987) Recent develop-ments in Parkinson's disease. Macmillan, Florham Park, NJ, pp 153-163
116. Pascual-Leone A, Amedi A, Fregni F, Merabet LB (2005) The plastic human brain cortex. Ann Rev Neurosci 28: 377-401